Gene Therapy in Oncology

Complete study of the global Gene Therapy in Oncology market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Gene Therapy in Oncology industry. Research techniques like PESTLE and Porter’s Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Gene Therapy in Oncology production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

Key companies operating in the global Gene Therapy in Oncology market include , Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine, Geron Corp, Idera Pharmaceuticals, Intellia Therapeutics, Johnson & Johnson, Marsala Biotech, Merck, Mologen AG, Oncolytics Biotech, Oncosec, Oncotelic, Shenzhen SiBiono GeneTech, Sillajen Biotherapeutics, Tocagen, UniQure, Ziopharm Oncology Gene Therapy in Oncology

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

www.qyresearch.com/sample-form/form/1690461/covid-19-impact-on-global-gene-therapy-in-oncology-market

Segmental Analysis

The report has classified the global Gene Therapy in Oncology industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Gene Therapy in Oncology manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Gene Therapy in Oncology industry.

Global Gene Therapy in Oncology Market Segment By Type:

, Ex Vivo, In Vivo Gene Therapy in Oncology

Global Gene Therapy in Oncology Market Segment By  Application:

, Hospitals, Diagnostics Centers, Research Institutes

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Gene Therapy in Oncology industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Gene Therapy in Oncology market include , Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine, Geron Corp, Idera Pharmaceuticals, Intellia Therapeutics, Johnson & Johnson, Marsala Biotech, Merck, Mologen AG, Oncolytics Biotech, Oncosec, Oncotelic, Shenzhen SiBiono GeneTech, Sillajen Biotherapeutics, Tocagen, UniQure, Ziopharm Oncology Gene Therapy in Oncology

Key questions answered in the report:

  • What is the growth potential of the Gene Therapy in Oncology market?
  • Which product segment will grab a lion’s share?
  • Which regional market will emerge as a frontrunner in coming years?
  • Which application segment will grow at a robust rate?
  • What are the growth opportunities that may emerge in Gene Therapy in Oncology industry in the years to come?
  • What are the key challenges that the global Gene Therapy in Oncology market may face in future?
  • Which are the leading companies in the global Gene Therapy in Oncology market?
  • Which are the key trends positively impacting the market growth?
  • Which are the growth strategies considered by the players to sustain hold in the global Gene Therapy in Oncology market?

Get Full Report in your inbox within 24 hours at USD(3900) 

www.qyresearch.com/settlement/pre/552977f7cf9de4ceeb9775a8b6a15df7,0,1,covid-19-impact-on-global-gene-therapy-in-oncology-market

TOC

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy in Oncology Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy in Oncology Industry
1.6.1.1 Gene Therapy in Oncology Business Impact Assessment – Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy in Oncology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Gene Therapy in Oncology Market Perspective (2015-2026)
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy in Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy in Oncology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in Oncology Players by Market Size
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy in Oncology Market Concentration Ratio
3.2.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2019
3.3 Gene Therapy in Oncology Key Players Head office and Area Served
3.4 Key Players Gene Therapy in Oncology Product Solution and Service
3.5 Date of Enter into Gene Therapy in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2021-2026)
5 Gene Therapy in Oncology Breakdown Data by Application (2015-2026)
5.1 Global Gene Therapy in Oncology Market Size by Application (2015-2020)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gene Therapy in Oncology Market Size (2015-2020)
6.2 Gene Therapy in Oncology Key Players in North America (2019-2020)
6.3 North America Gene Therapy in Oncology Market Size by Type (2015-2020)
6.4 North America Gene Therapy in Oncology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gene Therapy in Oncology Market Size (2015-2020)
7.2 Gene Therapy in Oncology Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy in Oncology Market Size by Type (2015-2020)
7.4 Europe Gene Therapy in Oncology Market Size by Application (2015-2020)
8 China
8.1 China Gene Therapy in Oncology Market Size (2015-2020)
8.2 Gene Therapy in Oncology Key Players in China (2019-2020)
8.3 China Gene Therapy in Oncology Market Size by Type (2015-2020)
8.4 China Gene Therapy in Oncology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gene Therapy in Oncology Market Size (2015-2020)
9.2 Gene Therapy in Oncology Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy in Oncology Market Size by Type (2015-2020)
9.4 Japan Gene Therapy in Oncology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gene Therapy in Oncology Market Size (2015-2020)
10.2 Gene Therapy in Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020)
11 India
11.1 India Gene Therapy in Oncology Market Size (2015-2020)
11.2 Gene Therapy in Oncology Key Players in India (2019-2020)
11.3 India Gene Therapy in Oncology Market Size by Type (2015-2020)
11.4 India Gene Therapy in Oncology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gene Therapy in Oncology Market Size (2015-2020)
12.2 Gene Therapy in Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
13.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Cold Genesys
13.2.1 Cold Genesys Company Details
13.2.2 Cold Genesys Business Overview and Its Total Revenue
13.2.3 Cold Genesys Gene Therapy in Oncology Introduction
13.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020)
13.2.5 Cold Genesys Recent Development
13.3 Advantagene
13.3.1 Advantagene Company Details
13.3.2 Advantagene Business Overview and Its Total Revenue
13.3.3 Advantagene Gene Therapy in Oncology Introduction
13.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020)
13.3.5 Advantagene Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview and Its Total Revenue
13.4.3 Amgen Gene Therapy in Oncology Introduction
13.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Gene Therapy in Oncology Introduction
13.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bio-Path Holdings
13.6.1 Bio-Path Holdings Company Details
13.6.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
13.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020)
13.6.5 Bio-Path Holdings Recent Development
13.7 CRISPR Therapeutics
13.7.1 CRISPR Therapeutics Company Details
13.7.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
13.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
13.7.5 CRISPR Therapeutics Recent Development
13.8 Editas Medicine
13.8.1 Editas Medicine Company Details
13.8.2 Editas Medicine Business Overview and Its Total Revenue
13.8.3 Editas Medicine Gene Therapy in Oncology Introduction
13.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020)
13.8.5 Editas Medicine Recent Development
13.9 Geron Corp
13.9.1 Geron Corp Company Details
13.9.2 Geron Corp Business Overview and Its Total Revenue
13.9.3 Geron Corp Gene Therapy in Oncology Introduction
13.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020)
13.9.5 Geron Corp Recent Development
13.10 Idera Pharmaceuticals
13.10.1 Idera Pharmaceuticals Company Details
13.10.2 Idera Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
13.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020)
13.10.5 Idera Pharmaceuticals Recent Development
13.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Company Details
10.11.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
10.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.11.5 Intellia Therapeutics Recent Development
13.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Details
10.12.2 Johnson & Johnson Business Overview and Its Total Revenue
10.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
10.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020)
10.12.5 Johnson & Johnson Recent Development
13.13 Marsala Biotech
10.13.1 Marsala Biotech Company Details
10.13.2 Marsala Biotech Business Overview and Its Total Revenue
10.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
10.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.13.5 Marsala Biotech Recent Development
13.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview and Its Total Revenue
10.14.3 Merck Gene Therapy in Oncology Introduction
10.14.4 Merck Revenue in Gene Therapy in Oncology Business (2015-2020)
10.14.5 Merck Recent Development
13.15 Mologen AG
10.15.1 Mologen AG Company Details
10.15.2 Mologen AG Business Overview and Its Total Revenue
10.15.3 Mologen AG Gene Therapy in Oncology Introduction
10.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020)
10.15.5 Mologen AG Recent Development
13.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Company Details
10.16.2 Oncolytics Biotech Business Overview and Its Total Revenue
10.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
10.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.16.5 Oncolytics Biotech Recent Development
13.17 Oncosec
10.17.1 Oncosec Company Details
10.17.2 Oncosec Business Overview and Its Total Revenue
10.17.3 Oncosec Gene Therapy in Oncology Introduction
10.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020)
10.17.5 Oncosec Recent Development
13.18 Oncotelic
10.18.1 Oncotelic Company Details
10.18.2 Oncotelic Business Overview and Its Total Revenue
10.18.3 Oncotelic Gene Therapy in Oncology Introduction
10.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020)
10.18.5 Oncotelic Recent Development
13.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Company Details
10.19.2 Shenzhen SiBiono GeneTech Business Overview and Its Total Revenue
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
10.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.19.5 Shenzhen SiBiono GeneTech Recent Development
13.20 Sillajen Biotherapeutics
10.20.1 Sillajen Biotherapeutics Company Details
10.20.2 Sillajen Biotherapeutics Business Overview and Its Total Revenue
10.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Introduction
10.20.4 Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.20.5 Sillajen Biotherapeutics Recent Development
13.21 Tocagen
10.21.1 Tocagen Company Details
10.21.2 Tocagen Business Overview and Its Total Revenue
10.21.3 Tocagen Gene Therapy in Oncology Introduction
10.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020)
10.21.5 Tocagen Recent Development
13.22 UniQure
10.22.1 UniQure Company Details
10.22.2 UniQure Business Overview and Its Total Revenue
10.22.3 UniQure Gene Therapy in Oncology Introduction
10.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2015-2020)
10.22.5 UniQure Recent Development
13.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Company Details
10.23.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
10.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020)
10.23.5 Ziopharm Oncology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

 

 

 



Source link